Source:http://linkedlifedata.com/resource/pubmed/id/18384155
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2008-11-6
|
pubmed:abstractText |
This review focuses on the pharmaceutical aspects of the development of drug eluting stents. It discusses the different processes that can be used to obtain a controlled release of a drug from the stent as well as the coatings therefore applied. Results obtained for stents already available on the market or in a far stage of development are discussed. In a final part possible future research areas as well as expected new evolutions in the design of drug eluting stents are presented.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1520-6017
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5047-60
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
Pharmaceutical aspects of drug eluting stents.
|
pubmed:affiliation |
Ziscoat N.V., Interleuvenlaan 62 Zone 2, B-3001 Heverlee, Belgium.
|
pubmed:publicationType |
Journal Article,
Review
|